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INTRODUCTION
Malignant lymphoma of the thyroid gland is rare, account-
ing for only 2-5% of all thyroid malignancies, and less than
2% of extranodal lymphomas (1). They are almost all B-cell
lymphomas of diffuse large B-cell lymphoma and marginal
zone B cell lymphoma of the mucosa-associated lymphoid
tissue (MALT) type (2). Primary thyroid T-cell lymphomas
are extremely rare, and are defined as a lymphomatous pro-
cess involving the thyroid gland without contiguous spread
or distant metastases from other areas of involvement at diag-
nosis (3). To date, less than twenty cases have been described
in the literature (4, 5). 
Here, we present an extremely rare case of primary thyroid
T-cell lymphoma of cytotoxic T-cell phenotype masquerad-
ing as lymphoepithelial lesions that are commonly found in
MALT-lymphoma. To our best knowledge, only three cases
showing lymphoepithelial lesions in the thyroid T-cell lym-
phomas have been reported in the literature (5-7).
CASE REPORT
A 48-yr-old Korean woman, presented with incidentally
found neck mass in July of 2006. Her past history was non-
specific. Until admission, she had been well without weight
loss or hoarseness. There was no familial history of autoim-
mune diseases. On thyroid sonography, 3.0 cm-sized solid
and cystic mass was detected in the right lobe of thyroid gland.
Laboratory test showed mild leukocytosis (12,430/mL). Thy-
roid function tests were normal (free T4; 0.9 ng/dL, T3; 119
ng/dL, TSH; 5.16 mg/mL) with increased anti-thyroglobulin
antibodies (11.25 unit/mL, reference: 0-0.3). She was serolog-
ically negative to human T-cell leukemia virus type I or human
immunodeficiency virus. 99Tc nuclear medicine scans showed
a large cold nodule in the right lobe. Fine needle aspiration
of the thyroid was done, and it was not informative with dry-
ing artifact. Diagnostic and therapeutic right lobectomy was
performed. Results of the staging work-up, which included
a computed tomography scan (neck, chest and abdomen), a
bone marrow examination, positron emission tomography
were negative. The tumor was stage I. She received eight cycles
of CHOP chemotherapy over 6 months. During the 25 months
of follow up, she is alive with no recurrence.
Materials and methods
Immunohistochemistry was done by avidin-biotin-perox-
idase complex methods using antibodies against CD3 (Dako,
Glostrup, Denmark, prediluted), CD20 (Dako, prediluted),
CD4 (Dako, prediluted), CD8 (Dako, prediluted), T-cell-
restricted intracellular antigen -1 (TIA-1, Dako, prediluted),
granzyme B (Dako, prediluted), bF-1 (Dako, prediluted) and
Ki-67 (Dako, prediluted). Polymerase chain reaction (PCR)
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Primary T-cell Lymphoma of the Thyroid Associated with Hashimoto’ s
Thyroiditis, Histologically Mimicking MALT-Lymphoma
Most of thyroid lymphomas are B-lineage, and T-cell lymphomas are rare. Here,
we report a case of primary thyroid T-cell lymphoma associated with Hashimoto’s
thyroiditis. A 48-yr-old woman presented with incidentally found neck mass. Histo-
logically, the resected right lobe of the thyroid was replaced by monomorphic small
atypical lymphoid cells with lymphoepithelial lesion-like change, most of which were
immunoreactive for CD3, CD8, bF-1, and TIA-1. Peripheral T-cell lymphoma, unspec-
ified, was finally diagnosed after molecular study for TCR-g gene rearrangement.
This is the second case of cytotoxic T-cell lymphoma reported in the thyroid gland
so far. Unique association between thyroid follicles and neoplastic lymphocytes may
be characteristic feature of this type of T-cell lymphoma.
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formed using formalin-fixed, paraffin-embedded specimens
as described previously (8). To cover the range of the TCR g-
chain gene, the four main groups of the variable region (Vg1-
8, Vg9, Vg10, and Vg11) and Jg1/Jg2 consensus primers were
used for TCR-g gene rearrangement amplification and PCR
products were analyzed by nonradioactive single strand con-
formation polymorphism (SSCP). 
RESULTS
Excised specimen was composed of right lobectomy, mea-
suring 5.3×4.0×2.0 cm, and weighing 12.7 grams. The
external surface was unremarkable. The cut surface was glis-
tening brown tan and homogeneous and ill-defined firm lesion
measured 2.5×1.5×0.6 cm. Histologically, small lymphoid
cells diffusely replaced the parenchyma, which were infiltrat-
ing the residual thyroid follicles with formation of lymphoep-
ithelial lesion (Fig. 1). These cells were relatively uniform,
small round cells having slightly irregular nuclei with slight-
ly coarse chromatin and small nucleoli. Mitotic figures were
occasionally seen. The surrounding atrophic thyroid epithe-
lia showed enlarged and eosinophilic granular cytoplasm with
Hu_rthle cell metaplasia. There were lymphoplasmacytic infil-
tration, lymphoid follicle formation with germinal centers,
and a few eosinophils. These findings were consistent with
Hashimoto’s thyroiditis. The immunophenotype of atypical
lymphoid cells was CD3+CD8+CD4-CD20-TIA-1+bF-
1+granzymeB-CD56-CD30- (Fig. 2). Immunostain for Ki-
67 proliferation index showed 1%. Above findings were strong-
ly suggestive of T-lineage lymphoma. For definitive diagno-
sis, molecular study for rearrangement of TCR-g gene was
performed. SSCP showed a monoclonal rearranged band for
Vg11 gene (Fig. 3).
From the above findings, she was diagnosed as peripheral
T-cell lymphoma of TCR a/b+ inactivated cytotoxic pheno-
type associated with Hashimoto’s thyroiditis.
DISCUSSION
Initially it was difficult to recognize the present case as a
T-lineage lymphoma under the light microscopy, because fol-
licular invasion by atypical small lymphocytes, i.e. lymphoep-
ithelial lesion, mimics MALT-type B-cell lymphoma. A lym-
phoepithelial lesion is a significant morphologic finding in
the diagnosis of MALT-type B-cell lymphoma, however, is not
specific for MALT-type B-cell lymphoma and similar intraglan-
dular or intraepithelial invasion of small lymphocytes can be
seen in Hashimoto’s thyroiditis, Sjogren’s disease, and ente-
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C, chemotherapy; R, radiation therapy; S, surgery; ADF, alive disease-free; mo, months; PCR, polymerase chain reaction; TCR, T-cell receptor.
Case 
number
Combined 
Hashimoto’s 
thyroiditis
Treatment Outcome Genetic analysis Age/sex Pathology type Author (yr)
1 Yamaguchi, 59/F g/d T cell lymphoma (CD3+ CD4- Southern blot  Present C+R 22 mo (ADF)
et al. (1997) [7] CD8-TCRd+TCRb-) (TCR d)
2 Raftopoulos,  72/M Diffuse, mixed, cleaved (CD4+) Inconclusive Present S+C+R 12 mo (ADF)
et al. (2001) [6]
3 Koida, et al.  61/M  Small to medium (CD4+CXCR3 Southern blot Present C 28 mo (ADF)
(2007) [5] CCR5 and the Th2-associated (TCR b)
marker ST2 (L), CD8-CD25-TCRab+) 
4 Kim, et al. (2008) 48/F a/b peripheral T-cell lymphoma  PCR (TCR g) Present S+C 28 mo (ADF)
(CD3+CD8+bF-1+TIA+)
Table 1. Summary of the primary thyroid T-cell lymphomas showing lymphoepithelial lesions
Fig. 1. Low power view of thyroid shows diffuse effacement of nor-
mal architecture by lymphoid infiltrates (H&E. Original magnifica-
tion ×100). Inset shows small atypical lymphocytes invading fol-
licles, creating lymphoepithelial lesions (H&E. Original magnifica-
tion ×400). ropathy-type T-cell lymphoma (9-11).
Among thyroid T cell lymphomas reported previously, lym-
phoepithelial lesion-like change has been described in only
3 cases (5-7) (Table 1). Including the present case, all of them
were associated with Hashimoto’s thyroiditis. It is well known
that MALT-type B-cell lymphoma arose in the background
of chronic inflammation and autoimmune disease and some
of them transformed to large B-cell lymphoma. In the thy-
roid gland, Hashimoto’s thyroiditis markedly increases the
risk of malignant lymphoma of thyroid gland and most of
associated lymphomas are either MALT-type B-cell lymphoma
or large B-cell lymphoma. Although there is no consensus
about pathogenetic relation between Hashimoto’s thyroidi-
tis and primary thyroidal T-cell lymphoma, association of
Hashimoto’s thyroiditis with thyroid T-cell lymphoma in pre-
sent case indicate that at least a part of thyroid T-cell lym-
phoma has a pathogenetic relation with Hashimoto’s thyroidi-
tis. Close association of follicular epithelial cells and neoplastic
lymphocytes simulating lymphoepithelial lesion of marginal
zone B-cell lymphoma may be characteristic finding of this
type of T-cell lymphoma. 
Because the infiltrated lymphocytes are phenotypically of
helper T-cell origin with a background of Hashimoto’s thy-
roiditis, it suggests that helper T-cell activation induced by
chronic inflammation could lead to peripheral T-cell lym-
phoma of themselves as well as MALT-type B-cell lympho-
ma. However, further study may be required in CD8+ cyto-
toxic T-cell lymphomas arising in the background of Hashi-
moto’s thyroiditis like the present case. These lymphoepithe-
lial lesions in the present case are similar to those of enteropa-
thy-type T-cell lymphoma; both individual T-lymphoma cells
invade thyroid follicular epithelium or intestinal crypt epithe-
lium. Both primary thyroid T-cell lymphoma and enteropa-
thy-type T-cell lymphoma may be tumors of intraepithelial
T-lymphocytes. Both are frequently associated with under-
lying autoimmune diseases such as celiac disease or Hashimo-
to’s thyroiditis.
On the absence of a reliable immunohistochemical marker
of clonality of T-lymphocytes, genetic study is the most use-
ful method to detect the presence of a dominant T-cell clone
in a lymphocytic infiltrate (2, 12). In recent days, gene rear-
rangement of immunoglobulins and TCR can be used as a
marker of thyroid lymphoma, particularly when the histo-
logic and immunohistochemical diagnosis of malignant lym-
phoma is inconclusive. The sensitivity of detecting thyroid
lymphoma by the Southern blot method is about 85% in
Matsuzuka’s series (13), while the sensitivity by PCR is 75%
in Torlakovic’s series (8). In Signoretti’s series, sensitivity rate
was elevated up to 95% of the T-cell lymphoma using all Vg1-
8, Vg9, Vg10, Vg11, and Jg1/Jg2 primers (14). Here, the pre-
sent case was confirmed as T-cell lymphoma because it show-
ed TCR-g gene rearrangement, in which monoclonality was
detected in Vg11 region. This diverges from that of other con-
ventional T-cell lymphomas which usually show monoclon-
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Fig. 2. Atypical small lymphocytes are
stained with CD3 (Peroxidase. Original
magnification ×400, A), CD8 (Peroxi-
dase. Original magnification ×400, B),
and cytoplasmic TIA-1-immunoreactivity
(Peroxidase. Original magnification ×400,
C). They are not stained with CD20 (Per-
oxidase. Original magnification ×400, D).
A B C D
Fig. 3. Gene rearrangement study for TCR using PCR-SSCP analy-
sis shows a monoclonal band. Lane M, 100 base pair DNA ladder
marker; Lane v1-8, Vg1-8 region; Lane v11, Vg11 region; -, nega-
tive control.
M v1-8 v11 (-)alities in Vg1-8 region. 
Treatment has not yet been fully established and no survival
statistics still exist for thyroid T-cell lymphoma. The patients
underwent surgery, chemotherapy and radiation, combined
therapy or untreated in the reports. The choice is cyclophos-
phamide, daunorubicin, vincristine and prednisolone (CHOP)
based chemotherapy (15). Peripheral T-cell lymphoma is known
to take worse prognosis than does B-cell lymphoma. How-
ever, though cases reported are rare, none of the cases of the
primary thyroid T-cell lymphomas except for one died from
the disease (16). Even in Okamoto’s report, cytotoxic TIA-1
expressing T-cell lymphoma showed partial spontaneous re-
gression before diagnostic hemithyroidectomy (17). 
Here, we report the second case of cytotoxic T-cell lym-
phoma in the thyroid gland, and unique association between
thyroid follicles and neoplastic T-lymphocytes, i.e. lymphoep-
ithelial lesion, may be characteristic feature of this type of
cytotoxic T-cell lymphoma.
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